AIMT - Aimmune Therapeutics Inc. (AIMT) CEO Jayson Dallas on Q2 2020 Results - Earnings Call Transcript
Aimmune Therapeutics, Inc. (AIMT)
Q2 2020 Earnings Conference Call
July 30, 2020, 16:30 ET
Company Participants
DeDe Sheel - VP, IR
Jayson Dallas - President, CEO & Director
Daniel Adelman - Chief Medical Officer
Andrew Oxtoby - Chief Commercial Officer
Eric Bjerkholt - CFO
Conference Call Participants
Vasiliana Moussatos - Wedbush Securities
Christopher Raymond - Piper Sandler & Co.
Charles Duncan - Cantor Fitzgerald & Co.
Jonathan Woo - Crédit Suisse
Bikramjot Singh - RBC Capital Markets
Boris Peaker - Cowen and Company
Kyuwon Choi - Goldman Sachs Group
Derek Archila - Stifel, Nicolaus &